434
Gums
β-glucans (see Beta-glucans)
classification of
acacia/arabic, 188
alginate, 191–192
animal origin, 193–195
dextrin, 193
gellan, 192
guar, 190
karaya, 190
microbial gums, 191
pectin, 189
tragacanth, 189
xanthan, 193
modification of
CM, 195–196
cross-linking, 195–196
grafting, 198–199
ultrasonic, 197–198
molecular weight of, 188
physiological effects, 205
structures of polysaccharides, 187
use of, 187
H
Hericium erinaceum, 99
Heterochlorella luteoviridis, 61
High amylose maize starch (HAM), 20
High-density lipoproteins (HDL), 51, 426
High methoxy pectin (HMP), 143–145, 158
High methoxyl (HM), 129
High-performance liquid chromatography
(HPLC), 100, 238
High-performance size-exclusion
chromatography (HPSEC), 101
HMG-CoA reductase, 424
Holoenzyme, 299
Homo lipids, 391
Homogalacturonan (HGA), 127, 140, 141
Hormones, 251
Horse chestnut (HSC), 78
Horseradish peroxidase (HRP), 287
Hot-water extraction, 95
Hydrochloric acid (HCl), 234
Hydrogenation, 407
Hydrophilic interaction chromatography
(HILIC), 240
Hydrophobic starch, 78
Hydrophobically modified starch (HMS), 417
Hydroxycinnamic acid (HCA), 358
Hydroxyethyl starch (HES), 79, 80
Hydroxylbenzoic acid (HBA), 358
Hypocholesterolemic effects, 425, 426
Hypoglyceamic property, 109, 110
Hypoglycemic effects, 420
blood glucose and plasma triglyceride
levels, 418
Cmax/AUC insulin, 418
diabetes mellitus, 254
dose-related pharmacological effects, 418
DPP-IV inhibitory, 255
essential oil, citrus reticulata, 419
GLP-1/GIP, 254
influence on glycaemia, 254
insulin, 255, 418
insulinotropic, 255
pancreatic cells, 418
type 1 diabetes, 418
type 2 diabetes, 254
vitamin A, 419
Hypolipidemic effects, 420
I
Ile-Pro-Pro (IPP), 256
Immobilization
biosensors, 330
entrapment/(micro)encapsulation, 330
enzymes/cells, 330
flavourzyme, 331
non-catalytic material, 330
polymer network, 330
Immunobiological methods
definition, 283
detection/measurement, 283
immunoelectrophoresis
biological molecules, 285
capillary, 285
CE-based separation, 285
two-stage technique, 284
immunostaining, 286, 287
IP, 285
IP-MS, 286
SDS-PAGE, 287–288
2-DE, 288
usage, 283
western blotting, 284
alkaline phosphatase, 284
elements, 284
NC, 283
proteolytic enzymes, 284
techniques, 283
Immunohistochemistry (IHC), 286
Immuno-modulatory property, 108
Immuno-precipitation (IP), 285
Immunostaining, 286, 287
Indomethacin, 197
Index
Gums
β-glucans (see Beta-glucans)
classification of
acacia/arabic, 188
alginate, 191–192
animal origin, 193–195
dextrin, 193
gellan, 192
guar, 190
karaya, 190
microbial gums, 191
pectin, 189
tragacanth, 189
xanthan, 193
modification of
CM, 195–196
cross-linking, 195–196
grafting, 198–199
ultrasonic, 197–198
molecular weight of, 188
physiological effects, 205
structures of polysaccharides, 187
use of, 187
H
Hericium erinaceum, 99
Heterochlorella luteoviridis, 61
High amylose maize starch (HAM), 20
High-density lipoproteins (HDL), 51, 426
High methoxy pectin (HMP), 143–145, 158
High methoxyl (HM), 129
High-performance liquid chromatography
(HPLC), 100, 238
High-performance size-exclusion
chromatography (HPSEC), 101
HMG-CoA reductase, 424
Holoenzyme, 299
Homo lipids, 391
Homogalacturonan (HGA), 127, 140, 141
Hormones, 251
Horse chestnut (HSC), 78
Horseradish peroxidase (HRP), 287
Hot-water extraction, 95
Hydrochloric acid (HCl), 234
Hydrogenation, 407
Hydrophilic interaction chromatography
(HILIC), 240
Hydrophobic starch, 78
Hydrophobically modified starch (HMS), 417
Hydroxycinnamic acid (HCA), 358
Hydroxyethyl starch (HES), 79, 80
Hydroxylbenzoic acid (HBA), 358
Hypocholesterolemic effects, 425, 426
Hypoglyceamic property, 109, 110
Hypoglycemic effects, 420
blood glucose and plasma triglyceride
levels, 418
Cmax/AUC insulin, 418
diabetes mellitus, 254
dose-related pharmacological effects, 418
DPP-IV inhibitory, 255
essential oil, citrus reticulata, 419
GLP-1/GIP, 254
influence on glycaemia, 254
insulin, 255, 418
insulinotropic, 255
pancreatic cells, 418
type 1 diabetes, 418
type 2 diabetes, 254
vitamin A, 419
Hypolipidemic effects, 420
I
Ile-Pro-Pro (IPP), 256
Immobilization
biosensors, 330
entrapment/(micro)encapsulation, 330
enzymes/cells, 330
flavourzyme, 331
non-catalytic material, 330
polymer network, 330
Immunobiological methods
definition, 283
detection/measurement, 283
immunoelectrophoresis
biological molecules, 285
capillary, 285
CE-based separation, 285
two-stage technique, 284
immunostaining, 286, 287
IP, 285
IP-MS, 286
SDS-PAGE, 287–288
2-DE, 288
usage, 283
western blotting, 284
alkaline phosphatase, 284
elements, 284
NC, 283
proteolytic enzymes, 284
techniques, 283
Immunohistochemistry (IHC), 286
Immuno-modulatory property, 108
Immuno-precipitation (IP), 285
Immunostaining, 286, 287
Indomethacin, 197
Index